| BCG | Bacillus Calmette-Guerin |
| CR3 | Compliment receptor 3 |
| CR3-DCC | CD3 dependent cellular cytotoxicity |
| DC | Dendritic cells |
| HIF-1α | Hypoxia-inducible factor-1α |
| IP | Intraperitoneal |
| ITAM | immunoreceptor tyrosine-based activation motif |
| IV | Intravenous |
| LLC | Lewis lung carcinoma |
| mAb | Monoclonal antibodies |
| MAC-1 | Macrophage 1 Antigen |
| MDSCs | Myeloid-derived suppressor cells |
| MIF | Migration inhibitory factor |
| M-MDSC | Monocytic MDSC |
| MRD | Minimal residual disease- Minimal residual disease |
| mTOR | mammalian target of Rapamycin |
| ORR | Objective response rate |
| PAMPs | Pathogen-associated molecular patterns |
| PI3K | Phosphatidylinositol-3-kinase |
| PMN-MDSC | Polymorphonuclear MDSC |
| PRR | Pattern recognition receptor |
| TAM | Tumor-associated macrophages- Tumor-associated macrophages |
| TME | Tumor microenvironment |
| Tregs | Regulatory T cells |
| WGP | Whole glucan particles |